Header Logo

Connection

SETH LERNER to Phenylurea Compounds

Back to Details
This is a "connection" page, showing publications SETH LERNER has written about Phenylurea Compounds.
SETH LERNER
Connection Strength
0.049
Phenylurea Compounds
  1. Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial. Future Oncol. 2022 Jul; 18(21):2599-2614.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.